ANKRD15 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the ankyrin repeat domain-containing protein 15 (ANKRD15), a protein involved in various cellular processes, including protein-protein interactions and signal transduction. ANKRD15 is characterized by the presence of ankyrin repeat motifs, which are known to mediate the interaction between proteins and play a role in a wide range of biological functions such as cell cycle regulation, development, and differentiation. Inhibitors of ANKRD15 typically function by interfering with these ankyrin repeat domains, thereby blocking the protein's ability to interact with other cellular components. This disruption can lead to changes in how signaling pathways are modulated and regulated within the cell.
The inhibition of ANKRD15 provides a useful method for studying the role of ankyrin repeat-containing proteins in cellular communication and organization. By preventing ANKRD15 from engaging in its normal interactions, researchers can explore how its inhibition affects key processes such as protein stability, localization, and the assembly of protein complexes. Since ankyrin repeat motifs are highly conserved across different proteins, understanding the specific inhibition of ANKRD15 also sheds light on the broader family of ankyrin repeat proteins and their diverse roles in cellular physiology. The study of ANKRD15 inhibitors contributes to the knowledge of how protein-protein interactions shape intracellular signaling and how the regulation of these interactions is vital for maintaining cellular functions, offering insights into the molecular underpinnings of complex biological systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Inhibits a broad range of protein kinases, which may lead to reduced phosphorylation of ANKRD15, assuming it is a phosphoprotein. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which may decrease AKT signaling and subsequently affect ANKRD15, assuming it is part of this signaling cascade. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, potentially altering stress response pathways that regulate ANKRD15. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which may downregulate ERK signaling and could affect ANKRD15 if it is regulated by this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which may affect protein synthesis and degradation pathways involving ANKRD15. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, potentially reducing ERK pathway activity, which may affect ANKRD15 activity or stability. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which may alter transcription factor activity and affect ANKRD15's expression or function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Inhibits the proteasome, potentially increasing the half-life of ANKRD15 if it is normally degraded by this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which may impact numerous signaling pathways, including those regulating ANKRD15. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits CaMKII, potentially affecting calcium signaling pathways that regulate ANKRD15. | ||||||